Ledger.Open graph →
SEC Form D · filed January 28, 2016

Aprecia Pharmaceuticals Co

Offering
$84.0M
Sold
$79.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANGHORNE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

James T. Evans · Cincinnati, OHDirectorEtienne T. Perold · Pennington, NJDirectorJonathan T. Leff · New York, NYDirectorPhilip Cater · George Town, Grand Cayman, Cayman IslandsDirectorCato Partners GP, LLC · New York, NYDirectorMichael T. Rolhfs · Blue Ash, OHExecDavid T. Furniss · Mason, OHExecRobert T. Williford · Cincinnati, OHExecLawrence T. Glassmann · Cincinnati, OHDirectorE T. Arington · Mason, OHDirectorDonald T. Wetherhold · Loveland, OHExecPeter S. Grosskopf · Toronto, Ontario, CanadaDirectorArthur R. Rule, Iv · Toronto, Ontario, CanadaDirectorMichael T. Rolhfs · Blue Ash, OHExecDavid T. Furniss · Mason, OHExecRobert T. Williford · Cincinnati, OHExecLawrence T. Glassmann · Cincinnati, OHDirectorE T. Arington · Mason, OHDirectorDonald T. Wetherhold · Loveland, OHExecJonathan T. Leff · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗